About
AvoMD, founded in 2018 in New York, USA, developed an AI-powered no-code app builder that enables physicians and hospitals to build their own applications for any medical specialty.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2023-06Seed$5M
Investors · Las Olas Venture Capital, Epsilon Health, AlleyCorp, MedMountain VenturesSource · SVTR Weekly #007
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- AvoMD
AI-based no-code app builder
Seed · $5M · 2023-06
$5M
United States
BusinessLatest roundTotal raisedDate- Pluto Bio
No-code tools that help pharma and biotech teams analyze and visualize complex biological data
Undisclosed · $4M · 2025-05
$4M - Akkio
No-code platform that lets businesses execute tasks with AI in minutes
Series A · $15M · 2023-08
$15M - HumanFirst
No-code platform for creating new enterprise applications and processes
Seed · $4M · 2023-07
$4M
Europe
BusinessLatest roundTotal raisedDate- Viso
Low-code/no-code end-to-end platform for enterprises to build computer vision applications
Seed · $9M · 2023-10
$9M - Intelecy
No-code AI platform for industrial engineers and plant operators, with no manual coding required
Undisclosed · $4M · 2023-07
$4M - Genie
Low-/no-code tools that help data scientists, researchers and engineers use Julia, the company-created programming language for high-performance computing
Seed · $1M · 2023-10
$1M
Other / unspecified
BusinessLatest roundTotal raisedDate- Spiritt
No-code AI platform for building complex applications
Seed · $14M · 2023-07
$14M - Frontline.io
No-code platform that turns 3D models into interactive digital twins
Series A · $10M · 2025-04
$10M - Zenity
Security and governance tools built for low-code, no-code and AI development platforms
Series B · $55M · 2024-11
$55M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 19 at a nearby stage · 36 in NYC Metro
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 31 in NYC Metro
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 11 at a nearby stage · 22 in NYC Metro
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 7 at a nearby stage · 20 in NYC Metro
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in NYC Metro
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 5 at a nearby stage · 15 in NYC Metro
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.